**Specifications table**TableSubject areaBiotechnologyMore specific subject areaProteomicsType of dataExcel Tables and FigureHow data was acquiredLTQ-Orbitrap XL mass spectrometer (Thermo Scientific), Progenesis QI for Proteomics (Non-linear Dynamics, Waters) and Proteome Discoverer software (Thermo Scientific)Data formatRelative quantitation calculated and qualitative analysisExperimental factorsSubcellular enrichment for of CHO DP12 control cells and cells depleted of microRNA-378Experimental featuresQuantitative proteomic profiling of CHO DP12 cells following microRNA-378 depletionData source locationDublin, IrelandData accessibilityData available in this articleRelated research articleCostello, A., Coleman, O., Lao, N.T., Henry, M., Meleady, M., Barron, N. & Clynes, M. Depletion of Endogenous miRNA-378-3p Increases Peak Cell Density of CHO DP12 Cells and is Correlated with Elevated Levels of Ubiquitin Carboxyl-Terminal Hydrolase 14. Journal of Biotechnology, [@bib1]

**Value of the data**•This data reveals protein expression patterns associated with microRNA-378.•Differentially expressed proteins between control and miR-378 depleted CHO cells may serve as indicators of CHO cell growth.•This dataset reports enriched proteins from the cytosolic and membrane subcellular fractions of CHO DP12 cells.•This data provides proteomic profiles for two time-points of CHO DP12 batch culture; exponential and stationary phase.

1. Data {#s0005}
=======

The data presents a quantitative proteomic profiling of subcellular-enriched protein fractions from day 4 and day 8 cultures of CHO DP12 cells following microRNA-378 stable depletion. Both the cytosolic and membrane protein enriched fractions were analysed to identify significantly differentially expressed proteins between control and miR-378 depleted CHO cells (miR-378-spg) for each timepoint. Differentially expressed proteins between control and miR-378-spg cells are required to have (i) a *p-*value ≤ 0.05 on the peptide and the protein level and (ii) a minimum of 1.25-fold change in normalized abundance levels.

[Table 1](#t0005){ref-type="table"}, [Table 2](#t0010){ref-type="table"}, [Table 3](#t0015){ref-type="table"}, [Table 4](#t0020){ref-type="table"} list the differentially expressed proteins with an increased abundance in miR-378 depleted cells when compared to control cells. Proteins with an increased abundance in miR-378-spg cells represent potential direct targets of miR-378 in CHO cells and are of most interest. [Table 1](#t0005){ref-type="table"}, [Table 2](#t0010){ref-type="table"}, [Table 3](#t0015){ref-type="table"}, [Table 4](#t0020){ref-type="table"} report the accession number, peptide count, number of unique peptides, ANOVA *p*-value, q-value, maximum fold-change and protein name. [Supplementary Table S1](#s0045){ref-type="sec"} presents the complete list of all differentially overexpressed and under expressed proteins for each subcellular fraction and time-point. [Supplementary Table S2](#s0045){ref-type="sec"} presents the qualitative list of all identified proteins for each condition (control and miR-378-spg), subcellular enriched fraction (cytosolic and membrane protein enriched) and time-point (day 4 and day 8 of culture). Heat maps are shown in [Fig. 1](#f0005){ref-type="fig"} that outlines the clustering of significantly increased versus decreased proteins in miR-378-spg cells, as compared to control cells.Table 1Mass spectrometric identification of 28 proteins from the cytosolic enriched protein fraction with ≥ 1.25-fold increase in the miR-378 depleted CHO cells on day 4 of cell culture.Table 1**AccessionPeptidesUnique peptidesAnova (p)*Q* valueMax fold changeProtein name**625285532111.08E−022.96E−021.51Splicing factor 3B subunit 3625233305225.27E−031.98E−021.45Ubiquitin carboxyl-terminal hydrolase 14 isoform X4354504493991.24E−031.13E−021.446-phosphogluconate dehydrogenase, decarboxylating isoform X1625250820447.81E−032.69E−021.43Copine-1 isoform X3354500682112.00E−023.88E−021.41Cytochrome b5625231502113.25E−024.62E−021.40Leucine-rich repeat-containing protein 47 isoform X2, partial625204380332.23E−047.06E−031.37Chloride intracellular channel protein 4 isoform X1625279800115.08E−031.95E−021.37Caveolin-1 isoform X1354481364113.55E−024.65E−021.36crk-like protein isoform X1625258134119.24E−032.76E−021.35Sulfiredoxin-1 isoform X2625290509113.70E−024.65E−021.34T-complex protein 1 subunit beta isoform X2350537945992.38E−031.35E−021.33Peroxiredoxin-1625225560225.72E−047.39E−031.32Heterogeneous nuclear ribonucleoprotein A1 isoform X1625260720111.75E−023.77E−021.31TAR DNA-binding protein 43 isoform X1354477234222.29E−023.97E−021.30F-actin-capping protein subunit alpha-2 isoform X1354502560221.95E−031.35E−021.30Protein DJ-1354480001111.29E−023.06E−021.30T-complex protein 1 subunit delta354495613119.68E−032.82E−021.30Thrombomodulin625250988112.32E−023.97E−021.29Inositol-3-phosphate synthase 1 isoform X2625224185111.14E−022.99E−021.29Spermidine synthase62528008810104.60E−031.85E−021.28Alpha-enolase isoform X3625234360114.51E−024.89E−021.28Glutaredoxin-3 isoform X2625280141222.09E−031.35E−021.28Cytosolic acyl coenzyme A thioester hydrolase isoform X2625258715114.84E−031.90E−021.26Branched-chain-amino-acid aminotransferase, cytosolic isoform X3625267589113.94E−031.70E−021.26Alpha-actinin-4 isoform X2625233493114.49E−024.89E−021.2626S proteasome non-ATPase regulatory subunit 13 isoform X3625237309221.62E−031.30E−021.25Adenosylhomocysteinase625240103221.88E−023.81E−021.25T-complex protein 1 subunit epsilonTable 2Mass spectrometric identification of 73 proteins from the cytosolic enriched protein fraction with ≥ 1.25-fold increase in the miR-378 depleted CHO cells on day 8 of cell culture.Table 2**AccessionPeptidesUnique peptidesAnova (p)*Q* valueMax fold changeProtein name**625185523113.14E−025.71E−0318.2460S ribosomal protein L26 isoform X1625188420113.92E−025.85E−0310.57Heterogeneous nuclear ribonucleoprotein A3 isoform X1350539695111.13E−025.34E−037.67Protein disulfide-isomerase precursor346421364114.09E−025.85E−037.35Calreticulin precursor625242946114.88E−026.22E−034.95protein S100-A4625223066113.69E−025.85E−034.7860S ribosomal protein L22 isoform X1625195560114.30E−026.00E−034.45Protein disulfide-isomerase A6625229196224.03E−025.85E−034.1340S ribosomal protein S6354478978112.80E−025.71E−033.70protein S100-A6625203562112.20E−025.51E−032.8414-3-3 protein beta/alpha354495666113.30E−025.71E−032.7460S ribosomal protein L27a isoform X1625237172113.93E−025.85E−032.67Cathepsin D625272649114.01E−025.85E−032.66Nucleophosmin isoform X4625191956113.70E−025.85E−032.64Glucosidase 2 subunit beta isoform X1625221706552.41E−025.51E−032.60Alpha-enolase isoform X2354499455223.84E−025.85E−032.3460S ribosomal protein L29625193837114.78E−026.22E−032.3160S ribosomal protein L4 isoform X1346986359223.15E−025.71E−032.28Calreticulin precursor350539629114.93E−026.22E−032.2140S ribosomal protein S4625278207112.91E−025.71E−032.09Transcription elongation factor B polypeptide 2 isoform X2625234436333.74E−025.85E−032.04Acyl-CoA-binding protein625290232112.66E−025.51E−031.8960S ribosomal protein L18 isoform X2625194917111.47E−025.34E−031.8814-3-3 protein gamma350537945772.26E−025.51E−031.85Peroxiredoxin-1625225560334.53E−026.15E−031.85Heterogeneous nuclear ribonucleoprotein A1 isoform X1625265794111.13E−025.34E−031.8460S ribosomal protein L35a350537423443.03E−025.71E−031.7978 kDa glucose-regulated protein precursor354484084223.84E−025.85E−031.7740S ribosomal protein S3a354487474553.26E−025.71E−031.75Endoplasmin625242866333.26E−025.71E−031.74Tropomyosin alpha-3 chain isoform X7625271377113.10E−025.71E−031.73Peptidyl-prolyl cis-trans isomerase FKBP4 isoform X2350538733113.20E−025.71E−031.7160S ribosomal protein L13625218325111.98E−025.45E−031.71Y-box-binding protein 3, partial625219233221.46E−025.34E−031.71Heterogeneous nuclear ribonucleoprotein D0, partial354497356113.08E−025.71E−031.69ADP-ribosylation factor 3625286340114.66E−026.16E−031.66Annexin A5354507332111.72E−025.34E−031.6360S ribosomal protein L8346227155332.10E−025.46E−031.62Elongation factor 2625223526111.81E−025.39E−031.5940S ribosomal protein S3 isoform X1625233305335.51E−042.52E−031.58Ubiquitin carboxyl-terminal hydrolase 14 isoform X4625263837111.23E−025.34E−031.55Reticulocalbin-3 isoform X2625204380112.26E−025.51E−031.55Chloride intracellular channel protein 4 isoform X1354506476221.53E−025.34E−031.54Glutathione S-transferase Mu 7625190571332.60E−025.51E−031.47Tropomyosin alpha-4 chain354497863112.57E−025.51E−031.45RNA-binding protein FUS isoform X1625203986222.64E−025.51E−031.44Peptidyl-prolyl cis-trans isomerase A354475571112.89E−025.71E−031.42NSFL1 cofactor p47 isoform X1625198438112.48E−025.51E−031.42Ran-specific GTPase-activating protein625282303111.94E−025.45E−031.40Serine/threonine-protein kinase SMG1 isoform X3625223520221.48E−025.34E−031.39Serpin H1 isoform X1625190791112.90E−034.00E−031.3960S ribosomal protein L7a-like354471594112.06E−025.45E−031.38Cathepsin B625227859331.48E−025.34E−031.37Glutathione S-transferase Mu 6625258134113.04E−025.71E−031.37Sulfiredoxin-1 isoform X2625225201111.69E−025.34E−031.35Annexin A2 isoform X1625262042221.34E−025.34E−031.35Heat shock protein beta-1 isoform X2625180993221.11E−025.34E−031.34Eukaryotic initiation factor 4A-I-like350540646114.13E−025.85E−031.32Phosphoglycerate kinase 1625222844332.44E−041.80E−031.32Septin-11 isoform X1625240830112.66E−025.51E−031.31Nucleoside diphosphate kinase B625222011114.63E−026.16E−031.30inosine-5׳-monophosphate dehydrogenase 2 isoform X1625289462113.93E−025.85E−031.30Calcium-regulated heat stable protein 1625199022111.31E−025.34E−031.30m7GpppX diphosphatase354489619112.61E−025.51E−031.29Isocitrate dehydrogenase \[NADP\] cytoplasmic625249460221.10E−025.34E−031.29src substrate cortactin625202098114.66E−026.16E−031.29Myosin light polypeptide 6-like625256794221.36E−041.60E−031.29Fatty acid-binding protein, adipocyte350538479223.11E−025.71E−031.28Tubulin beta-6 chain625267589553.71E−034.07E−031.28Alpha-actinin-4 isoform X2625206697112.49E−025.51E−031.26ATP-binding cassette sub-family F member 1 isoform X1354483012221.40E−025.34E−031.25Heterogeneous nuclear ribonucleoprotein R625249889114.29E−034.53E−031.25Caldesmon isoform X3354465044112.33E−025.51E−031.25rab GDP dissociation inhibitor betaTable 3Mass spectrometric identification of 7 proteins from the membrane protein enriched fraction with ≥ 1.25-fold increase in the miR-378 depleted CHO cells on day 4 of cell culture.Table 3**AccessionPeptidesUnique peptidesAnova (p)*Q* valueMax fold changeProtein name**350538167112.35E−023.75E−021.52Calnexin precursor354495613222.29E−023.71E−021.37Thrombomodulin625263837332.63E−032.00E−021.34Reticulocalbin-3 isoform X2350537945333.71E−032.34E−021.33Peroxiredoxin-1625249714113.11E−023.99E−021.31Perilipin-4 isoform X14625282737114.67E−024.88E−021.31Protein dpy-30 homolog625215083331.83E−023.38E−021.30Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1 isoform X1Table 4Mass spectrometric identification of 72 proteins from the membrane protein enriched fraction with ≥ 1.25-fold increase in the miR-378 depleted CHO cells on day 8 of cell culture.Table 4**AccessionPeptidesUnique peptidesAnova (p)*Q* valueMax fold changeProtein name**625244585221.10E−022.45E−022.52Histone H2A.V isoform X2354496412116.56E−032.14E−022.45Histone H1.0354480100552.14E−023.33E−022.17Histone H2B type 1354494381111.63E−041.65E−022.12Fibronectin isoform X1354494231119.56E−032.38E−022.08High mobility group nucleosome-binding domain-containing protein 5 isoform X1345842361113.64E−024.43E−022.08High mobility group protein HMG-I/HMG-Y625206001771.31E−022.76E−022.06Histone H3.1-like625285909331.01E−022.38E−021.84Histone H2A type 1-H-like isoform X1625229196114.46E−024.84E−021.8140S ribosomal protein S6625205207112.86E−031.65E−021.77rRNA 2׳-O-methyltransferase fibrillarin, partial354480104661.53E−022.89E−021.74Histone H1.4 isoform X1625289934113.81E−024.46E−021.73Calumenin isoform X2350537403112.63E−023.77E−021.68DNA topoisomerase 2-alpha625262546113.48E−024.36E−021.68Replication protein A 14 kDa subunit625209863111.44E−022.87E−021.67Alpha-parvin625234125441.10E−022.45E−021.63Elongation factor 1-gamma350538167331.78E−031.65E−021.60Calnexin precursor625284147118.52E−032.30E−021.50Legumain350539823114.09E−041.65E−021.50Heat shock cognate 71 kDa protein625204124114.42E−024.82E−021.47Platelet glycoprotein 4625256908113.23E−031.65E−021.47Septin-2625211254222.82E−023.86E−021.47Plectin isoform X1625260069117.33E−032.14E−021.4414-3-3 protein epsilon isoform X2354504493221.54E−031.65E−021.446-phosphogluconate dehydrogenase, decarboxylating isoform X1625231575227.14E−032.14E−021.43Eukaryotic initiation factor 4A-II isoform X1625274484114.37E−024.80E−021.42Serum albumin isoform X3625262669113.56E−024.39E−021.42Cellular nucleic acid-binding protein isoform X2625243141112.10E−023.32E−021.41ATP-dependent RNA helicase DDX39A625216841116.75E−032.14E−021.41Coronin-1B625292335111.81E−023.04E−021.40High mobility group protein B2 isoform X2354489619117.40E−032.14E−021.40Isocitrate dehydrogenase \[NADP\] cytoplasmic625215758112.88E−031.65E−021.39Enoyl-CoA delta isomerase 1, mitochondrial isoform X1354483223112.25E−023.44E−021.39Prolyl 4-hydroxylase subunit alpha-1 isoform X1354467247112.41E−031.65E−021.39NADH dehydrogenase \[ubiquinone\] 1 alpha subcomplex subunit 9, mitochondrial625284339331.46E−022.87E−021.38Succinate dehydrogenase ubiquinone\] iron-sulfur subunit, mitochondrial isoform X2, partial625231917112.18E−023.36E−021.38Guanine nucleotide-binding protein subunit beta-4625238921114.00E−024.53E−021.38EH domain-containing protein 4 isoform X2354500398111.25E−031.65E−021.37Ubiquitin-like modifier-activating enzyme 1 isoform X1625190571112.57E−023.74E−021.35Tropomyosin alpha-4 chain354485048113.51E−024.37E−021.35Polymerase I and transcript release factor354485701114.91E−041.65E−021.35Stomatin-like protein 2, mitochondrial354492573114.19E−024.72E−021.35Actin-related protein 3B isoform X1354465900221.57E−022.93E−021.35ATP-dependent RNA helicase DDX3X isoform X1354484391112.57E−023.74E−021.3514-3-3 protein zeta/delta625190862111.66E−022.97E−021.34NADH dehydrogenase \[ubiquinone\] 1 alpha subcomplex subunit 10, mitochondrial isoform X1625240103114.16E−031.83E−021.34T-complex protein 1 subunit epsilon625188420114.22E−024.73E−021.33Heterogeneous nuclear ribonucleoprotein A3 isoform X1625211596116.89E−041.65E−021.3360S ribosomal protein L7 isoform X1625248231112.96E−031.65E−021.33ADP/ATP translocase 1 isoform X2625251833112.86E−023.86E−021.32Hydroxymethylglutaryl-CoA lyase, mitochondrial isoform X3350540646221.59E−022.93E−021.32Phosphoglycerate kinase 1625254434116.32E−032.14E−021.32Superoxide dismutase \[Mn\], mitochondrial isoform X2625249635115.33E−032.06E−021.31lon protease homolog, mitochondrial625208910114.97E−025.03E−021.30Septin-7 isoform X1354486011114.29E−024.74E−021.30Acyl-coenzyme A thioesterase 1 isoform X1625213146119.70E−032.38E−021.29Integrin beta-1 isoform X1625232358334.03E−041.65E−021.29Lipoprotein lipase isoform X1625279800114.90E−025.00E−021.28Caveolin-1 isoform X1625235290114.73E−024.89E−021.28Peroxiredoxin-5, mitochondrial625215083221.26E−031.65E−021.28Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1 isoform X1346986359332.62E−031.65E−021.27Elongation factor 1-alpha 1625201330111.81E−023.04E−021.27Cell division control protein 42 homolog625288359221.73E−023.01E−021.27dephospho-CoA kinase domain-containing protein552953713111.43E−022.87E−021.2640S ribosomal protein S7354482483112.73E−023.82E−021.26vimentin625243995223.76E−024.46E−021.26Leucine-rich PPR motif-containing protein, mitochondrial isoform X2625184898113.26E−024.24E−021.2539S ribosomal protein L12, mitochondrial isoform X1625236680111.11E−022.45E−021.2560 kDa heat shock protein, mitochondrial625183009221.37E−022.85E−021.25Triosephosphate isomerase isoform X1354486540222.91E−031.65E−021.25Hydroxymethylglutaryl-CoA synthase, mitochondrial625224152112.50E−023.72E−021.25Nuclear body protein SP140-like isoform X1625291524113.79E−024.46E−021.25Mitochondrial import inner membrane translocase subunit Tim13 isoform X3, partialFig. 1Heat maps of differentially expressed proteins in miR-378-spg CHO cells. A and B show the clustering of significantly increased and decreased proteins identified in the cytosolic enriched fraction of miR-378-spg cells for day 4 and day 8, respectively. C and D show the clustering of differentially expressed proteins identified in the membrane enriched fraction of miR-378-spg when compared to control on day 4 and day 8 of culture, respectively. The normalised abundance values of differentially expressed proteins were log2 transformed and hierarchical Pearson clustering was performed on Z-score normalised intensity values.Fig. 1

2. Experimental design, materials and methods {#s0010}
=============================================

2.1. Subcellular protein extraction and in-solution protein digestion {#s0015}
---------------------------------------------------------------------

Triplicate biological samples for control and miR-378 depleted cells were collected on day 4 and day 8 of batch cultures. Subcellular protein enrichment was achieved using the Mem-Per Plus Membrane protein extraction kit (\#89842, Thermo Fisher Scientific) which yielded a cytosolic and membrane protein enriched fraction. Protein concentration was determined using the QuickStart Bradford assay (Bio-rad). Equal concentrations (100 µg) of protein from each sample were purified and trypsin digested for mass spectrometry using the filter-aided sample preparation method as previously described [@bib2]. The resulting peptide samples were purified using Pierce C18 spin columns then dried using vacuum centrifugation and suspended in 2% acetonitrile and 0.1% trifluoracetic acid in LC grade water prior to LC-MS/MS analysis.

2.2. Label-free liquid chromatography mass spectrometry {#s0020}
-------------------------------------------------------

Quantitative label-free liquid-chromatography mass spectrometry (LC--MS/MS) analysis of mir-378-spg and NC-spg membrane and cytosolic fractions from day 4 and day 8 was carried out using a Dionex UltiMate™ 3000 RSLCnano system (Thermo Fisher Scientific) coupled to a hybrid linear LTQ Orbitrap XL mass spectrometer (Thermo Fisher Scientific). LC-MS/MS methods were applied as previously described [@bib3]. A 5 μL injection of each sample was loaded onto a C18 trapping column (PepMap100, C18, 300 μm × 5 mm; Thermo Fisher Scientific). Each sample was desalted for 5 min using a flow rate of 25 μL/min with 2% ACN, 0.1% TFA before being switched online with the analytical column (PepMap C18, 75 μm ID × 250 mm, 3 μm particle and 100 Å pore size; (Thermo Fisher Scientific)). Peptides were eluted using a binary gradient of Solvent A (2% ACN and 0.1% formic acid in LC grade water) and Solvent B (80% ACN and 0.08% formic acid in LC grade water). The following gradient was applied; 6--25% solvent B for 120 min and 25--50% solvent B in a further 60 min at a column flow rate of 300 nL/min. Data was acquired with Xcalibur software, version 2.0.7 (Thermo Fisher Scientific). The LTQ Orbitrap XL was operated in data-dependent mode with full MS scans in the 400--1200 m/z range using the Orbitrap mass analyser with a resolution of 30,000 (at m/z 400). Up to three of the most intense ions (+1, +2, and +3) per scan were fragmented using collision-induced dissociation (CID) in the linear ion trap. Dynamic exclusion was enabled with a repeat count of 1, repeat duration of 20 s, and exclusion duration of 40 s. All tandem mass spectra were collected using a normalized collision energy of 32%, and an isolation window of 2 m/z with an activation time of 30 ms.

2.3. Quantitative label-free LC-MS/MS data analysis {#s0025}
---------------------------------------------------

Protein identification was achieved using Proteome Discoverer 2.1 with the Sequest HT and MASCOT algorithm followed by Percolator validation [@bib4] to apply a false-discovery rate \< 0.01. Data was searched against the NCBI Chinese Hamster (*Cricetulus griseus*) protein database containing 44,065 sequences (fasta file downloaded November 2015). The following search parameters were used for protein identification: (1) precursor mass tolerance set to 20 ppm, (2) fragment mass tolerance set to 0.6 Da, (3) up to two missed cleavages were allowed, (4) carbamidomethylation of cysteine set as a static modification and (5) methionine oxidation set as a dynamic modification. The complete lists of all identified proteins from the cytosolic and membrane enriched fractions of day 4 and day 8 cell cultures of the control (NC378-spg) and miR-378-spg are provided in [Supplementary Table S2](#s0045){ref-type="sec"}.

Quantitative label-free data analysis was performed using Progenesis QI for Proteomics (version 2.0; Nonlinear Dynamics, a Waters company) as described by the manufacturer ([www.nonlinear.com](http://www.nonlinear.com){#ir0005}). To counteract potential drifts in retention time a reference run was assigned to which all MS data files were aligned. The triplicate samples from the two experimental groups (NC-378-spg and miR-378-spg) were set up for differential analysis and label-free relative quantitation was carried out after peak detection, automatic retention time calibration and normalisation to account for experimental variation. The experimental analyses performed compared the three biological replicates for control cells to miR-378-spg triplicates for each timepoint and subcellular fraction collected. The following settings were applied to filter peptide features (1) peptide features with a one-way ANOVA p-value \< 0.05 between experimental groups, (2) mass peaks with charge states from +1 to +3 and (3) greater than one isotope per peptide. The normalised data is transformed prior to statistical analysis, using an arcsinh transformation to meet the assumptions of the one-way ANOVA test. A mascot generic file (mgf) was generated from all exported MS/MS spectra which satisfied the peptide filters, the mgf was used for peptide and protein identification in Proteome Discoverer. Protein identifications were imported into Progenesis and considered differentially expressed if they passed the following criteria: (i) a protein one-way ANOVA p-value \<0.05 and (ii) a ≥1.25-fold change in relative abundance between the two experimental groups. All differentially expressed proteins identified between NC378-spg and miR-378-spg cells are reported in [Supplementary Table S1](#s0045){ref-type="sec"}.

Heatmaps illustrating protein abundances for statistically significant and differentially expressed proteins were designed using ggplot2 in R-studio. The normalised abundance values of differentially expressed proteins were determined using Progenesis QI for Proteomics and were loaded as a txt file into R-studio and the data was log2 transformed. Hierarchical Pearson clustering was then performed on Z-score normalised intensity values by clustering both samples and proteins.
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